Loading...
XTSX
OBUL
Market cap5mUSD
, Last price  
CAD
Name

Imperial Ginseng Products Ltd

Chart & performance

D1W1MN
XTSX:OBUL chart
P/E
—
P/S
—
EPS
0.01
Vol. 1Y
—
Shs. 5Y
1.02%
Rev. 5Y
-4.09%
Div Yld LY
—
Div Yld TTM
—
Revenues
0
-100.00%
6,621,0003,963,0003,476,0003,893,0003,814,0005,054,0005,497,0003,583,0004,125,0009,117,0007,442,0007,512,00011,990,0004,506,0007,813,0005,788,0007,196,0003,444,0004,300,0000
Net income
208k
-92.85%
-1,243,000-947,000-646,000-605,000-857,000182,7911,735,000-467,0001,626,0003,894,0004,115,0001,335,0004,115,0004,730,000-4,953,000-7,354,000-4,482,0002,318,0002,917,000208,467
CFO
-1m
L
891,428-161,114-239,698-576,934-151,2241,512,2352,076,552-779,732350,2344,999,8972,600,7841,124,0055,769,653-2,777,491999,091-1,392,5902,575,8635,852,8301,017,046-1,320,982

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

Imperial Ginseng Products Ltd., established in 1989 and headquartered in Vancouver, Canada, specializes in the cultivation and processing of ginseng in Ontario. The company further extends its operations by supplying dried ginseng to wholesalers through its distribution channels in China.

Key people

Amelia Yeo
Chief Financial Officer · since 2010
Stephen Mccoach
Executive Chairman of the Board, Chief Executive Officer, Secretary · since 2020
Maurice Levesque
Independent Director · since 2022
Cam Hui
Non-Executive Independent Director · since 2020
IPO date
Jan 22, 1990
Employees
Domiciled in
CA
Incorporated in
CA

Valuation

Title
CAD in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFY
2024‑062023‑062022‑062021‑062020‑062019‑062018‑062017‑06
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT